Cardiac Science Corporation
As part of the agreement, ZOLL will acquire Cardiac Science’s product portfolio and pipeline, along with its facilities in the United States and Europe. Additional terms of the agreement are not being disclosed. The acquisition is subject to anti-trust regulatory approval and other customary closing conditions. Until closing, the companies will operate independently.